Co-Authors
This is a "connection" page, showing publications co-authored by Cédric Annweiler and Jean-Marc Sabatier.
Connection Strength
3.387
-
Neurological, Cognitive, and Behavioral Disorders during COVID-19: The Nitric Oxide Track. J Am Geriatr Soc. 2020 09; 68(9):1922-1923.
Score: 0.889
-
Point of view: Should COVID-19 patients be supplemented with vitamin D? Maturitas. 2020 Oct; 140:24-26.
Score: 0.886
-
Counter-regulatory 'Renin-Angiotensin' System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected Patients. Infect Disord Drug Targets. 2020; 20(4):407-408.
Score: 0.860
-
DAMPening Severe COVID-19 with Dexamethasone. Infect Disord Drug Targets. 2021 Aug 27.
Score: 0.241
-
Vitamin D and survival in COVID-19 patients: A quasi-experimental study. J Steroid Biochem Mol Biol. 2020 11; 204:105771.
Score: 0.227
-
Montelukast Drug May Improve COVID-19 Prognosis: A Review of Evidence. Front Pharmacol. 2020; 11:1344.
Score: 0.225
-
Capivasertib restricts SARS-CoV-2 cellular entry: a potential clinical application for COVID-19. Int J Biol Sci. 2021; 17(9):2348-2355.
Score: 0.059